Буфомикс Изихалер

Буфомикс Изихалер is an inhaled corticosteroid and long-acting beta2-agonist combination for maintenance treatment of respiratory conditions. It delivers budesonide and formoterol fumarate dihydrate directly to the lungs for effective symptom control. Suitable for adults and adolescents with asthma or COPD. Prescription required.

Буфомикс Изихалер is used to manage and prevent symptoms of asthma and chronic obstructive pulmonary disease (COPD). It combines an inhaled corticosteroid (budesonide) to reduce inflammation and a long-acting bronchodilator (formoterol) to open airways. This combination helps control wheezing, shortness of breath, and chest tightness. It is not for acute symptom relief.

Users may experience improved breathing and reduced frequency of asthma or COPD flare-ups over time. Some may notice a decrease in coughing and wheezing as the medication helps keep airways open. Regular use supports better daily activity levels and lung function. Individual responses vary.

Store at room temperature away from moisture and heat. Keep the inhaler clean and dry; avoid dropping or damaging the device. Rinse your mouth with water after use to reduce the risk of oral thrush. Follow the prescribed schedule and do not exceed the recommended dose.

Certain medications may affect how Буфомикс Изихалер works, including strong CYP3A4 inhibitors like ketoconazole or ritonavir. Beta-blockers (e.g., propranolol) may reduce the effectiveness of formoterol. Avoid combining with other long-acting beta2-agonists. Always inform your healthcare provider about all medications you are taking.